MARKET

CRMD

CRMD

Cormedix
NASDAQ
11.87
-0.61
-4.89%
Opening 15:16 12/31 EST
OPEN
12.45
PREV CLOSE
12.48
HIGH
12.45
LOW
11.80
VOLUME
2.48M
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
935.23M
P/E (TTM)
5.78
1D
5D
1M
3M
1Y
5Y
1D
Here's Why You Should Retain Community Health Stock for Now
NASDAQ · 12/31/2025 16:24
RARE Rises on Completion of Rolling Submission for AAV Gene Therapy
NASDAQ · 12/31/2025 14:50
VNDA Obtains FDA Nod for Motion Sickness Drug, Stock Gains
NASDAQ · 12/31/2025 12:36
RARE, MREO Tank as Osteogenesis Study Fails to Meet Primary Endpoint
NASDAQ · 12/30/2025 16:00
Kyverna Therapeutics Stock Up 41% in a Month: Here's Why
NASDAQ · 12/30/2025 12:58
Ocugen Stock Surges 75% Year to Date: What's in Store for 2026?
NASDAQ · 12/29/2025 14:53
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?
NASDAQ · 12/29/2025 14:50
Weekly Report: what happened at CRMD last week (1222-1226)?
Weekly Report · 12/29/2025 09:31
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.